vs

Side-by-side financial comparison of Cintas (CTAS) and OLIN Corp (OLN). Click either name above to swap in a different company.

Cintas is the larger business by last-quarter revenue ($2.8B vs $1.7B, roughly 1.7× OLIN Corp). Cintas runs the higher net margin — 17.7% vs -8.6%, a 26.3% gap on every dollar of revenue. On growth, Cintas posted the faster year-over-year revenue change (9.3% vs -0.4%). Over the past eight quarters, Cintas's revenue compounded faster (7.9% CAGR vs 0.9%).

Cintas Corporation is an American corporation headquartered in Mason, Ohio, which provides a range of products and services to businesses including uniforms, mats, mops, cleaning and restroom supplies, first aid and safety products, fire extinguishers and testing, and safety courses. Cintas is a publicly held company traded on the Nasdaq Global Select Market under the symbol CTAS and is a component of the S&P 500 Index.

Olin Corporation is an American manufacturer of ammunition, chlorine, and sodium hydroxide. The company traces its roots to two companies, both founded in 1892: Franklin W. Olin's Equitable Powder Company and the Mathieson Alkali Works. Accidents at Olin chemical plants have exposed employees and nearby residents to health hazards.

CTAS vs OLN — Head-to-Head

Bigger by revenue
CTAS
CTAS
1.7× larger
CTAS
$2.8B
$1.7B
OLN
Growing faster (revenue YoY)
CTAS
CTAS
+9.7% gap
CTAS
9.3%
-0.4%
OLN
Higher net margin
CTAS
CTAS
26.3% more per $
CTAS
17.7%
-8.6%
OLN
Faster 2-yr revenue CAGR
CTAS
CTAS
Annualised
CTAS
7.9%
0.9%
OLN

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
CTAS
CTAS
OLN
OLN
Revenue
$2.8B
$1.7B
Net Profit
$495.3M
$-143.2M
Gross Margin
50.4%
1.9%
Operating Margin
23.4%
-9.4%
Net Margin
17.7%
-8.6%
Revenue YoY
9.3%
-0.4%
Net Profit YoY
10.4%
-1517.8%
EPS (diluted)
$1.21
$-1.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTAS
CTAS
OLN
OLN
Q4 25
$2.8B
$1.7B
Q3 25
$2.7B
$1.7B
Q2 25
$2.7B
$1.8B
Q1 25
$2.6B
$1.6B
Q4 24
$2.6B
$1.7B
Q3 24
$2.5B
$1.6B
Q2 24
$2.5B
$1.6B
Q1 24
$2.4B
$1.6B
Net Profit
CTAS
CTAS
OLN
OLN
Q4 25
$495.3M
$-143.2M
Q3 25
$491.1M
$43.7M
Q2 25
$448.3M
$-2.8M
Q1 25
$463.5M
$1.2M
Q4 24
$448.5M
$10.1M
Q3 24
$452.0M
$-25.2M
Q2 24
$414.3M
$72.3M
Q1 24
$397.6M
$47.8M
Gross Margin
CTAS
CTAS
OLN
OLN
Q4 25
50.4%
1.9%
Q3 25
50.3%
10.7%
Q2 25
49.7%
7.9%
Q1 25
50.6%
9.0%
Q4 24
49.8%
9.4%
Q3 24
50.1%
8.5%
Q2 24
14.5%
Q1 24
12.7%
Operating Margin
CTAS
CTAS
OLN
OLN
Q4 25
23.4%
-9.4%
Q3 25
22.7%
4.8%
Q2 25
22.4%
2.0%
Q1 25
23.4%
2.7%
Q4 24
23.1%
2.8%
Q3 24
22.4%
1.0%
Q2 24
22.2%
8.3%
Q1 24
21.6%
5.9%
Net Margin
CTAS
CTAS
OLN
OLN
Q4 25
17.7%
-8.6%
Q3 25
18.1%
2.6%
Q2 25
16.8%
-0.2%
Q1 25
17.8%
0.1%
Q4 24
17.5%
0.6%
Q3 24
18.1%
-1.6%
Q2 24
16.8%
4.4%
Q1 24
16.5%
2.9%
EPS (diluted)
CTAS
CTAS
OLN
OLN
Q4 25
$1.21
$-1.25
Q3 25
$1.20
$0.37
Q2 25
$1.08
$-0.01
Q1 25
$1.13
$0.01
Q4 24
$1.09
$0.10
Q3 24
$1.10
$-0.21
Q2 24
$4.00
$0.62
Q1 24
$3.84
$0.40

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTAS
CTAS
OLN
OLN
Cash + ST InvestmentsLiquidity on hand
$200.8M
$167.6M
Total DebtLower is stronger
$2.4B
$2.8B
Stockholders' EquityBook value
$4.5B
$1.8B
Total Assets
$10.1B
$7.3B
Debt / EquityLower = less leverage
0.54×
1.55×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTAS
CTAS
OLN
OLN
Q4 25
$200.8M
$167.6M
Q3 25
$138.1M
Q2 25
$264.0M
Q1 25
$243.4M
Q4 24
$122.4M
$175.6M
Q3 24
$101.4M
Q2 24
$342.0M
Q1 24
$128.5M
Total Debt
CTAS
CTAS
OLN
OLN
Q4 25
$2.4B
$2.8B
Q3 25
$2.4B
$3.0B
Q2 25
$2.4B
$3.0B
Q1 25
$2.0B
$3.0B
Q4 24
$2.0B
$2.7B
Q3 24
$2.0B
$2.8B
Q2 24
$2.0B
$2.8B
Q1 24
$2.5B
$2.7B
Stockholders' Equity
CTAS
CTAS
OLN
OLN
Q4 25
$4.5B
$1.8B
Q3 25
$4.8B
$2.0B
Q2 25
$4.7B
$2.0B
Q1 25
$4.6B
$2.0B
Q4 24
$4.3B
$2.0B
Q3 24
$4.0B
$2.1B
Q2 24
$4.3B
$2.1B
Q1 24
$4.2B
$2.2B
Total Assets
CTAS
CTAS
OLN
OLN
Q4 25
$10.1B
$7.3B
Q3 25
$9.8B
$7.6B
Q2 25
$9.8B
$7.7B
Q1 25
$9.6B
$7.7B
Q4 24
$9.4B
$7.6B
Q3 24
$9.1B
$7.5B
Q2 24
$9.2B
$7.7B
Q1 24
$9.0B
$7.6B
Debt / Equity
CTAS
CTAS
OLN
OLN
Q4 25
0.54×
1.55×
Q3 25
0.51×
1.52×
Q2 25
0.52×
1.52×
Q1 25
0.44×
1.50×
Q4 24
0.47×
1.34×
Q3 24
0.50×
1.34×
Q2 24
0.47×
1.31×
Q1 24
0.58×
1.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTAS
CTAS
OLN
OLN
Operating Cash FlowLast quarter
$531.2M
$321.2M
Free Cash FlowOCF − Capex
$425.0M
FCF MarginFCF / Revenue
15.2%
Capex IntensityCapex / Revenue
3.8%
Cash ConversionOCF / Net Profit
1.07×
TTM Free Cash FlowTrailing 4 quarters
$1.8B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTAS
CTAS
OLN
OLN
Q4 25
$531.2M
$321.2M
Q3 25
$414.5M
$26.7M
Q2 25
$635.7M
$212.3M
Q1 25
$622.0M
$-86.0M
Q4 24
$441.4M
$141.7M
Q3 24
$466.7M
$189.9M
Q2 24
$693.0M
$90.6M
Q1 24
$657.1M
$81.0M
Free Cash Flow
CTAS
CTAS
OLN
OLN
Q4 25
$425.0M
Q3 25
$312.5M
$-44.4M
Q2 25
$521.1M
Q1 25
$522.1M
$-147.4M
Q4 24
$340.0M
$90.7M
Q3 24
$373.8M
$146.6M
Q2 24
$591.1M
$34.1M
Q1 24
$550.1M
$36.7M
FCF Margin
CTAS
CTAS
OLN
OLN
Q4 25
15.2%
Q3 25
11.5%
-2.6%
Q2 25
19.5%
Q1 25
20.0%
-9.0%
Q4 24
13.3%
5.4%
Q3 24
14.9%
9.2%
Q2 24
23.9%
2.1%
Q1 24
22.9%
2.2%
Capex Intensity
CTAS
CTAS
OLN
OLN
Q4 25
3.8%
Q3 25
3.8%
4.2%
Q2 25
4.3%
Q1 25
3.8%
3.7%
Q4 24
4.0%
3.1%
Q3 24
3.7%
2.7%
Q2 24
4.1%
3.4%
Q1 24
4.4%
2.7%
Cash Conversion
CTAS
CTAS
OLN
OLN
Q4 25
1.07×
Q3 25
0.84×
0.61×
Q2 25
1.42×
Q1 25
1.34×
-71.67×
Q4 24
0.98×
14.03×
Q3 24
1.03×
Q2 24
1.67×
1.25×
Q1 24
1.65×
1.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTAS
CTAS

Uniform Rental And Facility Services Segment$2.2B77%
First Aid And Safety Services Segment$342.2M12%
Fire Protection Services$222.5M8%
Uniform Direct Sales$79.8M3%

OLN
OLN

Chlorinechlorinederivativesandothercoproducts$456.2M27%
Causticsoda$400.2M24%
Militaryandlawenforcement$304.6M18%
Epoxyresins$194.9M12%
Aromaticsandallylics$164.4M10%
Commercial$144.8M9%

Related Comparisons